Swissmedic survey finds drug approval timelines slower than EMA, FDA

Regulatory NewsRegulatory NewsEuropeEuropean Medicines Agency (EMA)GenericsPharmaceuticalsRegulatory Intelligence/PolicySwissmedicUS Food and Drug Administration (FDA)